Avc

   
Google
 
Web NewDrugInformation.com

Avc


Drug - Avc
The trade name of the product as shown on the labeling.

Dosage - SUPPOSITORY; VAGINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sulfanilamide
Multiple ingredients are in alphabetical order.

Strength - 1.05GM
The potency of the active ingredient(s), Sulfanilamide. May repeat for multiple part products.

Applicant - PHARMELLE
The firm name holding legal responsibility for Avc. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 006530
The FDA assigned number to Avc. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Avc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 27, 1987
The date Avc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Avc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Avc is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmelle Llc
The full name of the firm holding legal responsibility for the new application of Avc.

Avc